Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

Sofiane Mohamed; Guillaume Penaranda; Dimitri Gonzalez; Claire Camus; Hacène Khiri; Ronan Boulmé; Chalom Sayada; Patrick Philibert; Daniel Olive; Philippe Halfon

Journal articles

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

Sofiane Mohamed ^{1, 2, *} Guillaume Penaranda ¹ Dimitri Gonzalez ³ Claire Camus ¹ Hacène Khiri ¹ Ronan Boulmé ³ Chalom Sayada ³ Patrick Philibert ⁴ Daniel Olive ² Philippe Halfon ¹

* Corresponding author

1 Alphabio Laboratory

2 CRCM - Centre de Recherche en Cancérologie de Marseille

3 Research and Development

4 Médecine générale

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadata

https://www.hal.inserm.fr/inserm-00995731
Contributor : Ed. BMC Connect in order to contact the contributor
Submitted on : Friday, May 23, 2014 - 5:04:08 PM
Last modification on : Friday, October 22, 2021 - 3:29:12 AM
Long-term archiving on: : Monday, August 25, 2014 - 11:35:49 AM

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

Files

Identifiers

Collections

Citation

Export

Metrics

164

251

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

Files

Identifiers

Collections

Citation

Export

Share

Metrics

164

251